SEC Form 4 · accession 0001127602-19-009106

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 27, 2019

Accepted (ET)

Mar 1, 2019 · 11:20 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 27, 2019	S	48	$141.585	D	286,240	D
Common Stock	Feb 27, 2019	S	100	$141.60	D	286,140	D
Common Stock	Feb 27, 2019	S	300	$141.64	D	285,840	D
Common Stock	Feb 27, 2019	S	18	$141.645	D	285,822	D
Common Stock	Feb 27, 2019	S	3	$141.65	D	285,819	D
Common Stock	Feb 27, 2019	S	30	$141.655	D	285,789	D
Common Stock	Feb 27, 2019	S	100	$141.67	D	285,689	D
Common Stock	Feb 27, 2019	S	460	$141.69	D	285,229	D
Common Stock	Feb 27, 2019	S	200	$141.70	D	285,029	D
Common Stock	Feb 27, 2019	S	5	$141.715	D	285,024	D
Common Stock	Feb 27, 2019	S	400	$141.72	D	284,624	D
Common Stock	Feb 27, 2019	S	200	$141.74	D	284,424	D
Common Stock	Feb 27, 2019	S	6	$141.765	D	284,418	D
Common Stock	Feb 27, 2019	S	134	$141.79	D	284,284	D
Common Stock	Feb 27, 2019	S	96	$141.795	D	284,188	D
Common Stock	Feb 27, 2019	S	200	$141.80	D	283,988	D
Common Stock	Feb 27, 2019	S	210	$141.805	D	283,778	D
Common Stock	Feb 27, 2019	S	100	$141.81	D	283,678	D
Common Stock	Feb 27, 2019	S	300	$141.83	D	283,378	D
Common Stock	Feb 27, 2019	S	130	$141.86	D	283,248	D
Common Stock	Feb 27, 2019	S	105	$141.87	D	283,143	D
Common Stock	Feb 27, 2019	S	88	$141.88	D	283,055	D
Common Stock	Feb 27, 2019	S	30	$141.885	D	283,025	D

No Table II lines on this filing.